CNS

#ECTRIMS2016 – Protein Seen as New Target in Preventing Brain Inflammation in MS

Researchers found that blocking a protein,Ā known asĀ integrin alpha 8, may workĀ to prevent inflammation in the central nervous system of patients with multiple sclerosis (MS). The results were revealedĀ in an oral presentation, ā€œIntegrin alpha8 is a novel mediator of T lymphocyte migration across the CNS barriers,ā€ atĀ theĀ 32nd Congress of theĀ European Committee…

Genzyme Announces New Research Collaboration With Ablynx for Innovative Multiple Sclerosis Therapeutic Project

This week, Belgian-based biopharmaceutical company Ablynx announced they have entered into an exclusive research collaboration with Genzyme, a Sanofi company, to investigate the use of Nanobodies as part of a targeted therapeutic strategy for multiple sclerosis (MS). Ā The research will utilize Genzymeā€™s early-stage MS research programs involving neuroprotection…